News Column

Torrent Pharma announces Q1 FY 14-15 results

July 31, 2014

ENP Newswire - 31 July 2014

Release date- 30072014 - .For Q1 FY 14-15 revenues were at Rs. 1,114 crores, up by 15% from Rs. 972 crores during the same period last year.

.EBITDA for Q1 FY 14-15 was at Rs. 346 crores up by 66% from Rs. 208 crores during the same period last year.

.PAT for the year (before minority interest) Q1 FY 14-15 was at Rs. 256 crores up by 72% compared to Rs. 149 crores during the same period last year.

Performance Highlights of Q1 FY 15

.Domestic formulation business recorded revenues of Rs. 356 crores, growing by 13%.

.International revenues grew by 36% to Rs. 733 crores. Adjusting for currency movements revenues grew by 27%.

.Revenues from US operations recorded growth of 138%.

.Operations in Brazil registered revenue growth of 12%.

Revenues from Europe (incl. Heumann) recorded a growth of 17%. Rest of the World including Russia & CIS operations recorded a de growth of 12%.

Business Initiatives

.During the quarter company consummated acquisition of Identified Indian Branded Formulations Business of Elder Pharmaceuticals Limited for a consideration of about Rs. 2000 cores.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: ENP Newswire

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters